XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2020 $ 116,399 $ 15 $ 190,568 $ (74,773) $ 589
Beginning Balance, shares at Dec. 31, 2020   15,476,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 8,838     8,838  
Other comprehensive income (loss), net of tax (711)       (711)
Issuance of restricted stock 113   113    
Issuance of restricted stock, shares   26,000      
Repurchase of common stock and retirement of related treasury shares (215)   (215)    
Repurchase of common stock and retirement of related treasury shares, shares   (6,000)      
Stock options exercised 912 $ 1 911    
Stock options exercised, shares   159,000      
Stock-based compensation 1,786   1,786    
Ending Balance at Mar. 31, 2021 127,122 $ 16 193,163 (65,935) (122)
Ending Balance, shares at Mar. 31, 2021   15,655,000      
Beginning Balance at Dec. 31, 2020 116,399 $ 15 190,568 (74,773) 589
Beginning Balance, shares at Dec. 31, 2020   15,476,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 10,559        
Other comprehensive income (loss), net of tax 94        
Ending Balance at Jun. 30, 2021 133,692 $ 16 197,207 (64,214) 683
Ending Balance, shares at Jun. 30, 2021   16,065,000      
Beginning Balance at Mar. 31, 2021 127,122 $ 16 193,163 (65,935) (122)
Beginning Balance, shares at Mar. 31, 2021   15,655,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,721     1,721  
Other comprehensive income (loss), net of tax 805       805
Issuance of restricted stock 1   1    
Issuance of restricted stock, shares   202,000      
Repurchase of common stock and retirement of related treasury shares (248)   (248)    
Repurchase of common stock and retirement of related treasury shares, shares   (9,000)      
Stock options exercised 2,350   2,350    
Stock options exercised, shares   217,000      
Stock-based compensation 1,941   1,941    
Ending Balance at Jun. 30, 2021 133,692 $ 16 197,207 (64,214) 683
Ending Balance, shares at Jun. 30, 2021   16,065,000      
Beginning Balance at Dec. 31, 2021 141,369 $ 16 198,278 (57,052) 127
Beginning Balance, shares at Dec. 31, 2021   16,168,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (6,476)     (6,476)  
Other comprehensive income (loss), net of tax (429)       (429)
Issuance of restricted stock, shares   30,000      
Stock options exercised 361   361    
Stock options exercised, shares   47,000      
Stock-based compensation 1,537   1,537    
Ending Balance at Mar. 31, 2022 136,362 $ 16 200,176 (63,528) (302)
Ending Balance, shares at Mar. 31, 2022   16,245,000      
Beginning Balance at Dec. 31, 2021 141,369 $ 16 198,278 (57,052) 127
Beginning Balance, shares at Dec. 31, 2021   16,168,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (24,302)        
Other comprehensive income (loss), net of tax $ (1,519)        
Stock options exercised, shares 71,379        
Ending Balance at Jun. 30, 2022 $ 119,653 $ 17 202,382 (81,354) (1,392)
Ending Balance, shares at Jun. 30, 2022   16,526,000      
Beginning Balance at Mar. 31, 2022 136,362 $ 16 200,176 (63,528) (302)
Beginning Balance, shares at Mar. 31, 2022   16,245,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (17,826)     (17,826)  
Other comprehensive income (loss), net of tax (1,090)       (1,090)
Issuance of restricted stock, shares   257,000      
Stock options exercised 177 $ 1 176    
Stock options exercised, shares   24,000      
Stock-based compensation 2,030   2,030    
Ending Balance at Jun. 30, 2022 $ 119,653 $ 17 $ 202,382 $ (81,354) $ (1,392)
Ending Balance, shares at Jun. 30, 2022   16,526,000